Ohio Pharmacy Law Practice Test

What information must be included on repackaged drug labels?

1. Patient's address

2. Repackager ID

3. Patient's name

4. Doctor's name

The correct answer is: Repackager ID

The inclusion of the repackager ID on repackaged drug labels is essential for ensuring accountability and traceability in the pharmaceutical supply chain. The repackager ID identifies the facility or organization that has performed the repackaging, providing a means to track where the drug was modified and by whom. This is particularly important for regulatory compliance, as it allows for oversight by regulatory bodies to ensure that repackaged drugs meet safety and quality standards. Including the repackager ID helps to maintain accurate records, which is crucial in the event of a recall or investigation related to the repackaged product. It provides a clear link back to the source of the medication, thus enhancing patient safety and maintaining the integrity of the medication distribution process. In contrast, elements such as the patient's name, address, or doctor's name are pertinent for prescription medications but not specifically required on the label of repackaged drugs, which emphasizes the importance of the repackager's identification in this context.